Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases
about
The ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and AR-mediated transcription.Human BRE1 is an E3 ubiquitin ligase for Ebp1 tumor suppressorEBP1 is a nucleolar growth-regulating protein that is part of pre-ribosomal ribonucleoprotein complexesHeregulin regulates the ability of the ErbB3-binding protein Ebp1 to bind E2F promoter elements and repress E2F-mediated transcriptionSpecificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signallingA novel single virus infection system reveals that influenza virus preferentially infects cells in g1 phaseStructural insights into the transcriptional and translational roles of Ebp1Nuclear recycling of the pre-60S ribosomal subunit-associated factor Arx1 depends on Rei1 in Saccharomyces cerevisiae.Phosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cellsIdentification of proteins associated with an IFNγ-responsive promoter by a retroviral expression system for enChIP using CRISPRNuclear Akt associates with PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase-activated DNaseEbp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity.Identification of Ebp1 as a component of cytoplasmic bcl-2 mRNP (messenger ribonucleoprotein particle) complexes.Alterations in cell growth and signaling in ErbB3 binding protein-1 (Ebp1) deficient miceNovel snail1 target proteins in human colon cancer identified by proteomic analysis.The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells.Post-transcriptional regulation of androgen receptor mRNA by an ErbB3 binding protein 1 in prostate cancer.Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cells.RORα binds to E2F1 to inhibit cell proliferation and regulate mammary gland branching morphogenesisQuantitative proteomics with siRNA screening identifies novel mechanisms of trastuzumab resistance in HER2 amplified breast cancers.Histone modification enzymes: novel targets for cancer drugs.Insights into gene expression changes impacting B-cell transformation: cross-species microarray analysis of bovine leukemia virus tax-responsive genes in ovine B cellsExpression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevanceP42 Ebp1 functions as a tumor suppressor in non-small cell lung cancer.The seed nuclear proteome.Co-regulated expression of alpha and beta mRNAs encoding HLA-DR surface heterodimers is mediated by the MHCII RNA operonThe role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies.The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cellsC-terminal domain of p42 Ebp1 is essential for down regulation of p85 subunit of PI3K, inhibiting tumor growth.The ERBB3 receptor in cancer and cancer gene therapyThe role of histone deacetylases in prostate cancer.Functional Genomics Identifies Tis21-Dependent Mechanisms and Putative Cancer Drug Targets Underlying Medulloblastoma Shh-Type Development.EBP1, a novel host factor involved in primer binding site-dependent restriction of moloney murine leukemia virus in embryonic cells.Small molecule regulators of Rb-E2F pathway as modulators of transcription.EBP1 and DRBP76/NF90 binding proteins are included in the major histocompatibility complex class II RNA operon.Modulation of HCV replication and translation by ErbB3 binding protein1 isoforms.Opposing roles of the two isoforms of ErbB3 binding protein 1 in human cancer cells.High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC).EBP1 protein modulates the expression of human MHC class II molecules in non-hematopoietic cancer cells.Novel factors modulating human β-cell proliferation.
P2860
Q24292959-59F61DA7-44A4-4D4F-B3B8-E49BE0EEAA1FQ24318682-8C8B17C9-8B46-402E-911E-0080B76F83C6Q24324400-A3E077E6-6F3D-4228-84D3-809B087D4F40Q24336095-F3F751CA-C00E-4A88-ABB0-F37FC5A03909Q24650935-DA747E05-8B3A-47B2-9D5C-31F6A0F3EA59Q27313237-BD892A10-9C84-4F91-B5E1-0A76522008C1Q27647107-866756E6-A691-4607-97FC-0607CB2590CAQ27930836-6A39B314-A77B-4CAC-8627-F41EE31A8102Q28269146-2195C365-6B82-48B9-A46B-4607FD93AD2CQ28541061-F79F166A-8DDC-46B9-875A-27BEAF93BE02Q28568026-001E74FC-EF4D-4C05-B865-7116F5B32318Q30493247-CD1147C9-579C-4CAC-96E4-57B158A8B367Q33231031-862B5846-8CE7-4A44-8BFA-30A38582CB7CQ33394396-D633B06C-0387-42EA-A8E1-458D649D58BCQ33565347-6CB95FE2-E025-4AC4-A973-C708D09B2241Q33896008-1B96B4F4-0EC2-4E40-87FF-E263E0288797Q33922404-3C5419C6-49E5-4CF5-8D76-9EDCCEE84579Q33962243-26D4B95B-1871-4F94-B82F-FDADA6A23ACCQ34056560-2406A376-8A01-471A-8045-1769B584AF0BQ34308692-F1CA1F54-A910-46A4-8CCD-14BB5146229AQ34322087-5A80F9FB-5978-4A7A-BA81-8B6519AC66B1Q34353406-379404A6-FDE6-46E4-A519-E7F9937DB360Q34461430-ED7B98C2-BF43-4BAA-AA21-64C333C606F8Q35676367-22F8F3A4-D803-42A5-BE80-349054CCD19FQ36479221-76252EC4-BE7D-4433-87E7-DD8676D29567Q36740824-81E26D83-D679-4B66-B15D-59A9956F5F95Q37006174-8825FB3E-EE5A-452F-B540-0EDA0CFBC2F4Q37006208-8A3986F5-5F74-47F1-94E7-6B1125636031Q37134220-ECF4CED8-37C1-4F8B-81EF-BB45FD41F979Q37135372-03203208-FEEA-4AD8-820F-AE14C04A5CEFQ37333510-0C49A9FF-A120-4466-9BFD-AF907DB62536Q37452592-493B8567-3606-4827-9606-82F2315A69C0Q37547250-0E331001-C2F2-4650-8590-DB04718A90B0Q37773559-1D41B066-EAAC-426C-8545-002771CBE364Q38318899-E0E1F866-0F83-487B-AB93-135D5494C366Q38738857-CFBCC2EC-F102-4BD7-8A87-722B5F78D05FQ38821292-1C039866-DFDD-40F5-BB28-D1F298E2D688Q38862381-83637A4A-99A3-4035-A76D-D92BF8D079BCQ38863174-AA5A6D47-C0D4-400B-818D-376CB2C2A78AQ38951158-E547B485-AD70-438D-A2A0-F6E8AA32CD65
P2860
Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Repression of E2F1-mediated tr ...... involves histone deacetylases
@ast
Repression of E2F1-mediated tr ...... involves histone deacetylases
@en
Repression of E2F1-mediated tr ...... involves histone deacetylases
@nl
type
label
Repression of E2F1-mediated tr ...... involves histone deacetylases
@ast
Repression of E2F1-mediated tr ...... involves histone deacetylases
@en
Repression of E2F1-mediated tr ...... involves histone deacetylases
@nl
prefLabel
Repression of E2F1-mediated tr ...... involves histone deacetylases
@ast
Repression of E2F1-mediated tr ...... involves histone deacetylases
@en
Repression of E2F1-mediated tr ...... involves histone deacetylases
@nl
P2093
P2860
P3181
P356
P1476
Repression of E2F1-mediated tr ...... involves histone deacetylases
@en
P2093
Anne W Hamburger
Nicholas Woodford
Xianmin Xia
Yuexing Zhang
P2860
P304
P3181
P356
10.1093/NAR/GKG318
P407
P577
2003-04-15T00:00:00Z